KPC Pharmaceuticals Inc
SSE:600422
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
KPC Pharmaceuticals Inc
SSE:600422
|
CN |
|
Beng Kuang Marine Ltd
SGX:BEZ
|
SG |
|
Kudan Inc
TSE:4425
|
JP |
|
T
|
Tallink Grupp AS
XMUN:T5N
|
EE |
|
G
|
Givaudan SA
F:GIN
|
CH |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
Keystone Law Group PLC
LSE:KEYS
|
UK |
|
O
|
Omni-Lite Industries Canada Inc
OTC:OLNCF
|
US |
|
G
|
Grindr Inc
NYSE:GRND
|
US |
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
CA |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
|
Electrovaya Inc
NASDAQ:ELVA
|
CA |
|
Sika AG
SIX:SIKA
|
CH |
|
Wirtek A/S
CSE:WIRTEK
|
DK |
|
L
|
Lucara Diamond Corp
SWB:LKT
|
CA |
Dividends
Dividend Yield
KPC Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
KPC Pharmaceuticals Inc
KPC Pharmaceuticals Inc have decreased by 0%.
Payout Ratio
KPC Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for KPC Pharmaceuticals Inc is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
KPC Pharmaceuticals Inc
| Average Annual Return | -0.34% |
| Standard Deviation of Annual Returns | 37.04% |
| Max Drawdown | -69% |
| Market Capitalization | 6.1B CNY |
| Shares Outstanding | 756 980 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
KPC Pharmaceuticals Inc's latest stock split occurred on May 9, 2016
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, KPC Pharmaceuticals Inc traded at 29.13 per share. Afterward, the share price was about 12.2998.
The adjusted shares began trading on May 9, 2016. This was stock split number 3 in KPC Pharmaceuticals Inc's history, following the previous one in Apr 18, 2005.